Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic immune-mediated disease from a group of spondyloarthritis, which is characterized by damage to the musculoskeletal system with a wide range of different clinical manifestations and is usually associated with psoriasis. Activation of the interleukin (IL) 23/IL17...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA-PRESS LLC
2020-11-01
|
| coleção: | Современная ревматология |
| Assuntos: | |
| Acesso em linha: | https://mrj.ima-press.net/mrj/article/view/1085 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|